Substance-Related and Addictive Disorders

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/281

flashcard set

Earn XP

Description and Tags

Psychopathology and Diagnostic Reasoning- Week 8/ Module 3

282 Terms

1
New cards
What are the 11 DSM-5-TR criteria for substance use disorder?
Taking more than intended, unsuccessful efforts to cut down, excessive time obtaining or using, craving, failure in major roles, social problems, reduced activities, hazardous use, continued use despite harm, tolerance, withdrawal
2
New cards
How is substance use disorder (SUD) severity classified?
Mild 2–3 criteria, moderate 4–5 criteria, severe 6 or more criteria within 12 months
3
New cards
What is the DSM-5-TR time frame for diagnosing SUD?
At least 2 of 11 criteria occurring within a 12-month period
4
New cards
What is the difference between substance use and substance use disorder?
Substance use is consumption, whereas SUD requires a problematic pattern causing clinically significant impairment or distress
5
New cards
What is craving in SUD?
A strong desire or urge to use a substance
6
New cards
What is tolerance?
Need for increased amounts to achieve the desired effect or diminished effect from the same amount
7
New cards
What is withdrawal?
Substance-specific symptoms following cessation or reduction after prolonged or heavy use
8
New cards
Does tolerance or withdrawal alone establish SUD in a patient taking medication as prescribed?
No, tolerance and withdrawal occurring during appropriate medical treatment do not independently count toward SUD diagnosis
9
New cards
What distinguishes intoxication from withdrawal?
Intoxication follows recent use and produces substance-specific effects, while withdrawal follows reduction or cessation after sustained use
10
New cards
What is a substance-induced mental disorder?
A psychiatric syndrome caused by intoxication, withdrawal, or medication exposure that is not better explained by an independent mental disorder
11
New cards
How can clinicians distinguish substance-induced psychiatric symptoms from an independent psychiatric disorder?
Assess symptom onset relative to use, intoxication, withdrawal, and abstinence, including whether symptoms preceded use or persist beyond expected substance effects
12
New cards
What is polysubstance use?
Use of multiple substances that may produce additive, synergistic, or opposing effects and complicate diagnosis and treatment
13
New cards
What is the first priority when assessing a patient with suspected intoxication or withdrawal?
Assess immediate medical stability, airway, breathing, circulation, vital signs, mental status, and risk of overdose or dangerous withdrawal
14
New cards
Which substance withdrawals can be life-threatening?
Alcohol and sedative-hypnotics, including benzodiazepines, can cause seizures and delirium
15
New cards
What is delirium tremens?
A severe, potentially fatal form of alcohol withdrawal involving delirium, autonomic hyperactivity, and often hallucinations
16
New cards
What is the priority treatment principle for potentially severe alcohol or benzodiazepine withdrawal?
Medically supervised withdrawal management, often with benzodiazepines and monitoring based on clinical severity
17
New cards
What is the opioid overdose triad?
Respiratory depression, decreased level of consciousness, and pinpoint pupils, although all three findings may not be present
18
New cards
What is the immediate treatment for suspected opioid overdose?
Support ventilation and airway, administer naloxone, and provide emergency monitoring and care
19
New cards
What is the mechanism of action of naloxone?
Competitive opioid receptor antagonist that rapidly reverses opioid effects, especially respiratory depression
20
New cards
What is the CAGE questionnaire used to screen for?

Potential problematic alcohol use using Cut down, Annoyed, Guilty, and Eye-opener questions; screens for potential alcohol and substance use disorders

21
New cards
What does AUDIT-C assess?
Alcohol consumption patterns using three screening questions
22
New cards
What does the Drug Abuse Screening Test (DAST) assess?
Potential drug-related problems, excluding alcohol and tobacco in its standard scoring approach
23
New cards
What does the CRAFFT screening tool assess?
Alcohol and drug-related risk in adolescents and young adults
24
New cards
What is SBIRT?
Screening, Brief Intervention, and Referral to Treatment for early identification and management of risky substance use
25
New cards
What is the purpose of motivational interviewing in SUD treatment?
Explore ambivalence and strengthen the patient's own motivation for behavior change without confrontation
26
New cards
What is harm reduction?
Strategies that reduce substance-related injury, illness, and death without requiring immediate abstinence
27
New cards
What is contingency management?
A behavioral intervention that reinforces desired behaviors, such as stimulant abstinence, with tangible rewards
28
New cards
Why does a positive urine drug screen not independently establish SUD?
Toxicology detects exposure to certain substances but does not establish the diagnostic criteria, impairment, or severity of SUD
29
New cards
Why does a negative urine drug screen not rule out substance use?
Detection depends on the substance, assay, timing, metabolism, and detection window
30
New cards
What is the purpose of confirmatory toxicology testing?
Verify unexpected or consequential screening results using a more specific analytical method
31
New cards
Which medical conditions can mimic intoxication or substance-related psychiatric symptoms?
Glucose abnormalities, thyroid disease, electrolyte disturbances, hepatic or renal dysfunction, seizures, TBI, delirium, infections, and nutritional deficiencies
32
New cards
Which laboratory studies may be appropriate in a substance-related diagnostic evaluation?
CBC, CMP, liver tests, TSH, B12 and folate, targeted toxicology, blood alcohol when indicated, and infection or pregnancy testing when clinically appropriate
33
New cards
When is an ECG particularly important in a substance-related evaluation?
Suspected cardiotoxic exposure, chest pain, syncope, significant tachycardia, or medications and substances that may prolong QT
34
New cards
What safety risks must be assessed in patients with SUD?
Overdose, suicidal ideation, self-harm, impaired driving, dangerous withdrawal, medical complications, and interactions between substances
35
New cards
What is the first-line medication for opioid use disorder?
Evidence-based options include buprenorphine and methadone, with extended-release naltrexone appropriate for selected patients
36
New cards
What is the mechanism of buprenorphine in opioid use disorder?

Partial mu-opioid receptor (full opioid agonists= heroin/oxycodone) agonist that reduces withdrawal and craving with a ceiling effect on respiratory depression; does not cause intense euphoria

37
New cards
What is the mechanism of methadone in opioid use disorder?
Full mu-opioid receptor agonist that suppresses withdrawal and craving during structured treatment
38
New cards
What is the mechanism of naltrexone in opioid and alcohol use disorders?

Competitive opioid receptor antagonist; binds tightly to mu-opioid receptors in the CNS without activating them; eliminates the high by blocking exogenous opioids from binding to the receptors. Blocking the reward pathway.

39
New cards
What must be verified before initiating naltrexone for opioid use disorder?

The patient must be opioid-free for 7-14 days to avoid sudden, severe opioid withdrawal

40
New cards
What are first-line medication options for alcohol use disorder?
Naltrexone or acamprosate, selected according to treatment goals, contraindications, and liver or renal function
41
New cards
What is the mechanism of acamprosate?

Acts as a functional glutamate antagonist and GABA-A/GABA-B modulator to restore chemical balance in the brain during alcohol recovery; Chronic alcohol use causes an overproduction of the excitatory neurotransmitter glutamate and upregulates NMDA.

42
New cards
What is disulfiram's mechanism and key safety concern?

Alcohol -> converted in liver to toxic acetaldehyde by alcohol dehydrogenase (ALDH) -> rapidly broken down into harmless acetic acid by ALDH. Disulfiram irreversibly inactivates ALDH. If alcohol is consumed while taking disulfiram, acetaldehyde accumulates rapidly in the bloodstream (5/10x)

43
New cards
What is the recommended approach to stimulant use disorder?
Contingency management has the strongest evidence, alongside psychosocial interventions and treatment of co-occurring conditions
44
New cards
What is the key diagnostic consideration for adolescent substance use?
Assess developmental context, school and family functioning, peer influences, access to substances, confidentiality limits, and safety
45
New cards
Why is confidentiality important when assessing adolescent substance use?

Private, nonjudgmental interviewing can build trust, encourage honest disclosures, and ensure young people actually seek help rather than hiding their behavior or avoiding care. Although clinicians must explain mandatory reporting obligations (harm to self or others, child abuse/neglect)

46
New cards
What ethical principle guides SUD assessment and treatment?
Respect autonomy and dignity, use nonstigmatizing language, protect confidentiality within legal limits, and prioritize safety
47
New cards
How should clinicians document suspected SUD when evidence is incomplete?
Document reported use, observed findings, functional impact, risks, collateral information, and diagnostic uncertainty without overstating conclusions
48
New cards
Which substances are classified as central nervous system depressants?

Alcohol, benzodiazepines, barbiturates, non-benzodiazepine sleep medications (Z-drugs; Ambien), and opioids/ narcotics.

49
New cards
What is the primary mechanism of alcohol's acute CNS effects?

Enhances GABA-A inhibitory signaling (reduces neuronal firing) and inhibits NMDA glutamate signaling (lowering overall brain excitation and impairing memory formation)

50
New cards
What are common signs of alcohol intoxication?
Impaired coordination, slurred speech, nystagmus, disinhibition, impaired judgment, and altered consciousness
51
New cards
What are the DSM-5-TR features of alcohol withdrawal?
Cessation or reduction after heavy prolonged use followed by symptoms such as tremor, sweating, nausea, insomnia, anxiety, agitation, or seizures
52
New cards
When does alcohol withdrawal typically begin?
Symptoms may begin within 6–24 hours after reduction or cessation, with timing and severity varying by individual
53
New cards
What is the CIWA-Ar used for?
Assessing and monitoring the severity of alcohol withdrawal in communicative patients
54
New cards
What is the first-line medication class for clinically significant alcohol withdrawal?
Benzodiazepines, with agent and dosing determined by severity and clinical context
55
New cards
What is the role of thiamine in chronic heavy alcohol use?
Prevents or treats deficiency-related neurologic injury, including Wernicke encephalopathy
56
New cards
What is Wernicke encephalopathy's classic triad?

Confusion, oculomotor abnormalities (rapid eye movements/nystagmus, double vision, or eye muscle weakness), and ataxia (loss of muscle coordination, unsteady gait, and balance problems), although the complete triad is often absent

57
New cards
What is the priority when Wernicke encephalopathy is suspected?
Give prompt parenteral thiamine and correct associated nutritional deficiencies, without delaying treatment for laboratory confirmation
58
New cards
What is Korsakoff syndrome?
A persistent amnestic disorder associated with thiamine deficiency, characterized by severe memory impairment and sometimes confabulation
59
New cards
What are the main symptoms of benzodiazepine intoxication?
Sedation, impaired coordination, slurred speech, confusion, and potentially respiratory depression, especially with other depressants
60
New cards
Why must chronic benzodiazepine use not be stopped abruptly?
Abrupt cessation can cause severe withdrawal, including seizures and delirium
61
New cards
What is the major danger of combining alcohol with opioids or benzodiazepines?
Additive CNS and respiratory depression, increasing the risk of fatal overdose
62
New cards
What are the primary signs of opioid withdrawal?

Muscle aches, lacrimation (watery eyes), rhinorrhea, yawning, sweating, dilated pupils, piloerection, abdominal cramps, diarrhea, and restlessness

63
New cards
Is opioid withdrawal usually life-threatening in otherwise healthy adults?
It is usually not directly life-threatening, but dehydration, pregnancy, comorbid illness, and relapse-related overdose create significant risks
64
New cards
What is precipitated opioid withdrawal?
Rapid onset of severe withdrawal when an opioid antagonist or partial agonist displaces full agonists before sufficient opioid clearance
65
New cards
What is the Clinical Opiate Withdrawal Scale (COWS) used for?
Quantifying opioid withdrawal severity and supporting treatment decisions
66
New cards
What is the role of nicotine in substance reinforcement?

Activates nicotinic acetylcholine receptors and stimulates reward pathways through increased dopamine signaling= makes other activities feel much more rewarding than they normally would

67
New cards
What are evidence-based first-line treatments for tobacco use disorder?
Behavioral counseling plus nicotine replacement therapy, varenicline, or bupropion when appropriate
68
New cards
What is varenicline's mechanism of action?
Partial agonist at alpha-4 beta-2 nicotinic acetylcholine receptors that reduces craving and withdrawal while diminishing nicotine reinforcement
69
New cards
What is bupropion's role in tobacco cessation?
Norepinephrine-dopamine reuptake inhibitor that reduces nicotine cravings and withdrawal symptoms
70
New cards
What is cannabis intoxication commonly associated with?
Impaired short-term memory, altered time perception, impaired coordination, increased appetite, and sometimes anxiety or paranoia
71
New cards
What are important features of cannabis withdrawal?
Irritability, anxiety, sleep difficulty, decreased appetite, restlessness, depressed mood, and physical discomfort
72
New cards
What is a key diagnostic risk associated with high-potency cannabis?
It can precipitate or worsen psychotic symptoms in susceptible individuals
73
New cards
What are common signs of stimulant intoxication?

Elevated alertness, euphoria, tachycardia, hypertension, mydriasis (pupil dilation), agitation, decreased appetite, and insomnia

74
New cards
What are potentially dangerous complications of stimulant intoxication?
Hyperthermia, arrhythmias, myocardial infarction, stroke, seizures, and severe agitation or psychosis
75
New cards
What are common symptoms of stimulant withdrawal?
Fatigue, increased sleep or insomnia, increased appetite, psychomotor changes, dysphoria, and craving
76
New cards
What is a major safety concern during stimulant withdrawal?
Severe depression and suicidal ideation, particularly during the post-intoxication crash
77
New cards
What is the mechanism of cocaine?

Blocks reuptake of dopamine, norepinephrine, and serotonin, increasing monoaminergic signaling; serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) and a voltage-gated sodium channel blocker

78
New cards
What is the mechanism of amphetamine?

Increases monoamine release and reverses transporter activity (these transporters pump dopamine and norepinephrine outward into the synaptic cleft), especially for dopamine, norepinephrine, and serotonin transporters

79
New cards
What is the priority assessment for a patient with severe stimulant-related agitation?
Evaluate vital signs, temperature, cardiovascular complications, glucose, hydration, mental status, and risk of harm
80
New cards
What are hallucinogens?
Substances that alter perception, cognition, and sensory experiences, including LSD and psilocybin
81
New cards
What is hallucinogen persisting perception disorder (HPPD)?

A rare condition in which a person experiences lasting or recurring visual disturbances and perceptual distortions long after the effects of a hallucinogenic or mind-altering drug have worn off

82
New cards
What is inhalant use disorder associated with?
Use of volatile substances or gases that can cause intoxication, cognitive impairment, cardiac arrhythmias, and sudden death
83
New cards
What is the DSM-5-TR diagnostic distinction between substance-induced psychosis and primary psychotic disorders?
Establish whether psychosis is temporally related to substance exposure and whether symptoms persist beyond expected effects or occur independently
84
New cards
What is the key principle in diagnosing co-occurring SUD and psychiatric disorders?
Assess both disorders independently while evaluating symptom chronology, substance effects, functional impairment, and persistence during abstinence
85
New cards
What is the difference between physical dependence and addiction?
Physical dependence involves adaptation causing withdrawal, whereas addiction involves compulsive use despite harmful consequences
86
New cards
What is cross-tolerance?
Tolerance to one substance reduces sensitivity to another substance with similar pharmacologic effects
87
New cards
What is sensitization in substance use?

An increased response to a substance after repeated exposure instead of a lower, potentially contributing to stimulant-related behavioral effects

88
New cards
What is the reward pathway most associated with substance reinforcement?
Mesolimbic dopamine pathway, particularly projections from the ventral tegmental area to the nucleus accumbens
89
New cards
What is the role of the prefrontal cortex in addiction?

Supports executive control, judgment, and inhibition, with its dysfunction being a core driver of the loss of control, compulsive drug-seeking, and impaired decision-making seen in addiction.

90
New cards
What is the difference between positive and negative reinforcement in substance use?

Positive reinforcement adds a rewarding effect (euphoria from a high/ social at a party), while negative reinforcement removes an unpleasant state such as withdrawal, anxiety, pain, or stress

91
New cards
What is the purpose of relapse-prevention interventions?
Identify triggers, strengthen coping skills, reduce exposure to high-risk situations, and support recovery after lapses
92
New cards
What is the DSM-5-TR diagnosis of gambling disorder classified under?
Substance-related and addictive disorders, within the non-substance-related addictive disorder category
93
New cards
What is the core feature of gambling disorder?
Persistent and recurrent problematic gambling causing clinically significant impairment or distress
94
New cards
How many DSM-5-TR criteria are required for gambling disorder?
At least 4 of 9 criteria within a 12-month period
95
New cards
What are the nine DSM-5-TR criteria for gambling disorder?
Needs increasing amounts to achieve excitement, restless or irritable when cutting down, repeated unsuccessful control attempts, preoccupation, gambling when distressed, chasing losses, lying, jeopardizing relationships or opportunities, relying on others for financial bailouts
96
New cards
How is gambling disorder severity classified?
Mild 4–5 criteria, moderate 6–7 criteria, severe 8–9 criteria
97
New cards
What does chasing losses mean in gambling disorder?
Returning to gamble after losing money in an attempt to recover losses
98
New cards
What is the first-line treatment approach for gambling disorder?
Cognitive behavioral therapy, motivational interventions, and treatment of co-occurring psychiatric or substance use disorders
99
New cards
What is the key difference between gambling disorder and recreational gambling?
Gambling disorder involves persistent loss of control and clinically significant impairment or distress
100
New cards
What is the most important initial step when assessing possible gambling disorder?
Assess gambling frequency, financial consequences, impaired control, functional impact, and suicide risk